Preterm Birth Prevention and Management Market By Drug Class (Progestogens, Tocolytics, Corticosteroids, Magnesium Sulfate, Antibiotics, Others) By Route of Administration (Vaginal, Intramuscular, Intravenous, Oral, Others) By End User (Hospitals, Maternity and Fertility Clinics, Ambulatory Surgical Centers, Others) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2026-2035

Table of Content

• 1. Research Methodology and Data Source
  • 1.1. Methodology/Research Approach
  • 1.2. Market Size Estimation
  • 1.3. Market Breakdown and Data Triangulation
  • 1.4. Data Sources
  • 1.5. Secondary Sources
  • 1.6. Primary Sources
• 2. Executive Summary
  • 2.1. Taxonomy
  • 2.2. Global Market Outlook
  • 2.3. Key Facts and Figures
  • 2.4. Major Players in Preterm Birth Prevention and Management Market
• 3. Global Market Overview
  • 3.1. Industry Overview
  • 3.2. Segmental Overview
  • 3.3. Regional Overview
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities
    • 3.4.4. Trends
  • 3.5. Regulatory Framework
  • 3.6. Opportunity Map Analysis
  • 3.7. Opportunity Orbits
  • 3.8. Market Investment Feasibility Index
  • 3.9. PESTLE Analysis
  • 3.10. PORTER’S Five Force Analysis
  • 3.11. Drivers & Restraints Impact Analysis
  • 3.12. Patient Journey Mapping
  • 3.13. Technological Landscape
  • 3.14. Product Life Cycle Analysis
  • 3.15. Value Chain Analysis
    • 3.15.1. List of Raw Material Suppliers
    • 3.15.2. List of Preterm Birth Prevention and Management Market Manufacturers
    • 3.15.3. List of Dealer/Distributors
    • 3.15.4. List of Potential Customers
  • 3.16. Cost Structure Analysis
  • 3.17. Regional Market Share and BPS Analysis
• 4. Macro-economic Factors
• 5. Impact of Current Geopolitical Scenario
• 6. Global Preterm Birth Prevention and Management Market Analysis and Forecast, By Drug Class
  • 6.1. Key Findings
  • 6.2. Global Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Drug Class, 2020-2035
    • 6.2.1. Progestogens
    • 6.2.2. Tocolytics
    • 6.2.3. Corticosteroids
    • 6.2.4. Magnesium Sulfate
    • 6.2.5. Antibiotics
    • 6.2.6. Others
  • 6.3. Global Preterm Birth Prevention and Management Market Attractiveness Analysis, By Drug Class
• 7. Global Preterm Birth Prevention and Management Market Analysis and Forecast, By Route of Administration
  • 7.1. Key Findings
  • 7.2. Global Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Route of Administration, 2020-2035
    • 7.2.1. Vaginal
    • 7.2.2. Intramuscular
    • 7.2.3. Intravenous
    • 7.2.4. Oral
    • 7.2.5. Others
  • 7.3. Global Preterm Birth Prevention and Management Market Attractiveness Analysis, By Route of Administration
• 8. Global Preterm Birth Prevention and Management Market Analysis and Forecast, By End User
  • 8.1. Key Findings
  • 8.2. Global Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By End User, 2020-2035
    • 8.2.1. Hospitals
    • 8.2.2. Maternity and Fertility Clinics
    • 8.2.3. Ambulatory Surgical Centers
    • 8.2.4. Others
  • 8.3. Global Preterm Birth Prevention and Management Market Attractiveness Analysis, By End User
• 9. Global Preterm Birth Prevention and Management Market Analysis and Forecast, By Region
  • 9.1. Key Findings
  • 9.2. Global Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Region, 2020-2035
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Middle East & Africa
    • 9.2.5. Latin America
  • 9.3. Global Preterm Birth Prevention and Management Market Attractiveness Analysis, By Region
• 10. North America Preterm Birth Prevention and Management Market Analysis and Forecast, 2020-2035
  • 10.1. Key Findings
  • 10.2. North America Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Drug Class, 2020-2035
  • 10.3. North America Preterm Birth Prevention and Management Market Attractiveness Analysis, By Drug Class
  • 10.4. North America Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Route of Administration, 2020-2035
  • 10.5. North America Preterm Birth Prevention and Management Market Attractiveness Analysis, By Route of Administration
  • 10.6. North America Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By End User, 2020-2035
  • 10.7. North America Preterm Birth Prevention and Management Market Attractiveness Analysis, By End User
  • 10.8. North America Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Country, 2020-2035
  • 10.9. North America Preterm Birth Prevention and Management Market Attractiveness Analysis, By Country
    • 10.9.1. The US Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Drug Class, 2020-2035
    • 10.9.2. The US Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Route of Administration, 2020-2035
    • 10.9.3. The US Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By End User, 2020-2035
    • 10.9.4. Canada Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Drug Class, 2020-2035
    • 10.9.5. Canada Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Route of Administration, 2020-2035
    • 10.9.6. Canada Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By End User, 2020-2035
• 11. Europe Preterm Birth Prevention and Management Market Analysis and Forecast, 2020-2035
  • 11.1. Key Findings
  • 11.2. Europe Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Drug Class, 2020-2035
  • 11.3. Europe Preterm Birth Prevention and Management Market Attractiveness Analysis, By Drug Class
  • 11.4. Europe Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Route of Administration, 2020-2035
  • 11.5. Europe Preterm Birth Prevention and Management Market Attractiveness Analysis, By Route of Administration
  • 11.6. Europe Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By End User, 2020-2035
  • 11.7. Europe Preterm Birth Prevention and Management Market Attractiveness Analysis, By End User
  • 11.8. Europe Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Country, 2020-2035
  • 11.9. Europe Preterm Birth Prevention and Management Market Attractiveness Analysis, By Country
    • 11.9.1. Germany Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Drug Class, 2020-2035
    • 11.9.2. Germany Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Route of Administration, 2020-2035
    • 11.9.3. Germany Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By End User, 2020-2035
    • 11.9.4. The U.K. Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Drug Class, 2020-2035
    • 11.9.5. The U.K. Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Route of Administration, 2020-2035
    • 11.9.6. The U.K. Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By End User, 2020-2035
    • 11.9.7. France Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Drug Class, 2020-2035
    • 11.9.8. France Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Route of Administration, 2020-2035
    • 11.9.9. France Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By End User, 2020-2035
    • 11.9.10. Spain Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Drug Class, 2020-2035
    • 11.9.11. Spain Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Route of Administration, 2020-2035
    • 11.9.12. Spain Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By End User, 2020-2035
    • 11.9.13. Italy Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Drug Class, 2020-2035
    • 11.9.14. Italy Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Route of Administration, 2020-2035
    • 11.9.15. Italy Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By End User, 2020-2035
    • 11.9.16. Russia & CIS Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Drug Class, 2020-2035
    • 11.9.17. Russia & CIS Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Route of Administration, 2020-2035
    • 11.9.18. Russia & CIS Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By End User, 2020-2035
    • 11.9.19. Rest of Europe Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Drug Class, 2020-2035
    • 11.9.20. Rest of Europe Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Route of Administration, 2020-2035
    • 11.9.21. Rest of Europe Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By End User, 2020-2035
• 12. Asia Pacific Preterm Birth Prevention and Management Market Analysis and Forecast, 2020-2035
  • 12.1. Key Findings
  • 12.2. Asia Pacific Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Drug Class, 2020-2035
  • 12.3. Asia Pacific Preterm Birth Prevention and Management Market Attractiveness Analysis, By Drug Class
  • 12.4. Asia Pacific Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Route of Administration, 2020-2035
  • 12.5. Asia Pacific Preterm Birth Prevention and Management Market Attractiveness Analysis, By Route of Administration
  • 12.6. Asia Pacific Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By End User, 2020-2035
  • 12.7. Asia Pacific Preterm Birth Prevention and Management Market Attractiveness Analysis, By End User
  • 12.8. Asia Pacific Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Country, 2020-2035
  • 12.9. Asia Pacific Preterm Birth Prevention and Management Market Attractiveness Analysis, By Country
    • 12.9.1. China Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Drug Class, 2020-2035
    • 12.9.2. China Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Route of Administration, 2020-2035
    • 12.9.3. China Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By End User, 2020-2035
    • 12.9.4. India Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Drug Class, 2020-2035
    • 12.9.5. India Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Route of Administration, 2020-2035
    • 12.9.6. India Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By End User, 2020-2035
    • 12.9.7. Japan Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Drug Class, 2020-2035
    • 12.9.8. Japan Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Route of Administration, 2020-2035
    • 12.9.9. Japan Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By End User, 2020-2035
    • 12.9.10. South Korea Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Drug Class, 2020-2035
    • 12.9.11. South Korea Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Route of Administration, 2020-2035
    • 12.9.12. South Korea Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By End User, 2020-2035
    • 12.9.13. ASEAN Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Drug Class, 2020-2035
    • 12.9.14. ASEAN Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Route of Administration, 2020-2035
    • 12.9.15. ASEAN Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By End User, 2020-2035
    • 12.9.16. Australia & New Zealand Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Drug Class, 2020-2035
    • 12.9.17. Australia & New Zealand Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Route of Administration, 2020-2035
    • 12.9.18. Australia & New Zealand Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By End User, 2020-2035
    • 12.9.19. Rest of Asia Pacific Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Drug Class, 2020-2035
    • 12.9.20. Rest of Asia Pacific Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Route of Administration, 2020-2035
    • 12.9.21. Rest of Asia Pacific Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By End User, 2020-2035
• 13. Middle East & Africa Preterm Birth Prevention and Management Market Analysis and Forecast, 2020-2035
  • 13.1. Key Findings
  • 13.2. Middle East & Africa Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Drug Class, 2020-2035
  • 13.3. Middle East & Africa Preterm Birth Prevention and Management Market Attractiveness Analysis, By Drug Class
  • 13.4. Middle East & Africa Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Route of Administration, 2020-2035
  • 13.5. Middle East & Africa Preterm Birth Prevention and Management Market Attractiveness Analysis, By Route of Administration
  • 13.6. Middle East & Africa Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By End User, 2020-2035
  • 13.7. Middle East & Africa Preterm Birth Prevention and Management Market Attractiveness Analysis, By End User
  • 13.8. Middle East & Africa Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Country, 2020-2035
  • 13.9. Middle East & Africa Preterm Birth Prevention and Management Market Attractiveness Analysis, By Country
    • 13.9.1. GCC Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Drug Class, 2020-2035
    • 13.9.2. GCC Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Route of Administration, 2020-2035
    • 13.9.3. GCC Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By End User, 2020-2035
    • 13.9.4. South Africa Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Drug Class, 2020-2035
    • 13.9.5. South Africa Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Route of Administration, 2020-2035
    • 13.9.6. South Africa Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By End User, 2020-2035
    • 13.9.7. Rest of Middle East & Africa Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Drug Class, 2020-2035
    • 13.9.8. Rest of Middle East & Africa Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Route of Administration, 2020-2035
    • 13.9.9. Rest of Middle East & Africa Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By End User, 2020-2035
• 14. Latin America Preterm Birth Prevention and Management Market Analysis and Forecast, 2020-2035
  • 14.1. Key Findings
  • 14.2. Latin America Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Drug Class, 2020-2035
  • 14.3. Latin America Preterm Birth Prevention and Management Market Attractiveness Analysis, By Drug Class
  • 14.4. Latin America Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Route of Administration, 2020-2035
  • 14.5. Latin America Preterm Birth Prevention and Management Market Attractiveness Analysis, By Route of Administration
  • 14.6. Latin America Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By End User, 2020-2035
  • 14.7. Latin America Preterm Birth Prevention and Management Market Attractiveness Analysis, By End User
  • 14.8. Latin America Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Country, 2020-2035
  • 14.9. Latin America Preterm Birth Prevention and Management Market Attractiveness Analysis, By Country
    • 14.9.1. Brazil Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Drug Class, 2020-2035
    • 14.9.2. Brazil Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Route of Administration, 2020-2035
    • 14.9.3. Brazil Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By End User, 2020-2035
    • 14.9.4. Mexico Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Drug Class, 2020-2035
    • 14.9.5. Mexico Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Route of Administration, 2020-2035
    • 14.9.6. Mexico Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By End User, 2020-2035
    • 14.9.7. Rest of Latin America Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Drug Class, 2020-2035
    • 14.9.8. Rest of Latin America Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By Route of Administration, 2020-2035
    • 14.9.9. Rest of Latin America Preterm Birth Prevention and Management Market Size Value (US$ Mn) Forecast, By End User, 2020-2035
• 15. Competitive Landscape & Company Profiles
  • 15.1. Market Competition Scenario Analysis, By Company
  • 15.2. Competitor Landscape
  • 15.3. Company Share Analysis
  • 15.4. Company Profiles
    • 15.4.1. AMAG Pharmaceuticals (Covis Pharma)
      • 15.4.1.1. Company Details
      • 15.4.1.2. Business Overview
      • 15.4.1.3. Product Portfolio
      • 15.4.1.4. Financial Insights
      • 15.4.1.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 15.4.1.6. SWOT Analysis
      • 15.4.1.7. Geographic Footprint
    • 15.4.2. Merck & Co., Inc.
      • 15.4.2.1. Company Details
      • 15.4.2.2. Business Overview
      • 15.4.2.3. Product Portfolio
      • 15.4.2.4. Financial Insights
      • 15.4.2.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 15.4.2.6. SWOT Analysis
      • 15.4.2.7. Geographic Footprint
    • 15.4.3. Ferring Pharmaceuticals
      • 15.4.3.1. Company Details
      • 15.4.3.2. Business Overview
      • 15.4.3.3. Product Portfolio
      • 15.4.3.4. Financial Insights
      • 15.4.3.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 15.4.3.6. SWOT Analysis
      • 15.4.3.7. Geographic Footprint
    • 15.4.4. Novartis AG
      • 15.4.4.1. Company Details
      • 15.4.4.2. Business Overview
      • 15.4.4.3. Product Portfolio
      • 15.4.4.4. Financial Insights
      • 15.4.4.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 15.4.4.6. SWOT Analysis
      • 15.4.4.7. Geographic Footprint
    • 15.4.5. Pfizer Inc.
      • 15.4.5.1. Company Details
      • 15.4.5.2. Business Overview
      • 15.4.5.3. Product Portfolio
      • 15.4.5.4. Financial Insights
      • 15.4.5.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 15.4.5.6. SWOT Analysis
      • 15.4.5.7. Geographic Footprint
    • 15.4.6. Bayer AG
      • 15.4.6.1. Company Details
      • 15.4.6.2. Business Overview
      • 15.4.6.3. Product Portfolio
      • 15.4.6.4. Financial Insights
      • 15.4.6.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 15.4.6.6. SWOT Analysis
      • 15.4.6.7. Geographic Footprint
    • 15.4.7. GlaxoSmithKline plc
      • 15.4.7.1. Company Details
      • 15.4.7.2. Business Overview
      • 15.4.7.3. Product Portfolio
      • 15.4.7.4. Financial Insights
      • 15.4.7.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 15.4.7.6. SWOT Analysis
      • 15.4.7.7. Geographic Footprint
    • 15.4.8. Johnson & Johnson
      • 15.4.8.1. Company Details
      • 15.4.8.2. Business Overview
      • 15.4.8.3. Product Portfolio
      • 15.4.8.4. Financial Insights
      • 15.4.8.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 15.4.8.6. SWOT Analysis
      • 15.4.8.7. Geographic Footprint
    • 15.4.9. Teva Pharmaceutical Industries Ltd
      • 15.4.9.1. Company Details
      • 15.4.9.2. Business Overview
      • 15.4.9.3. Product Portfolio
      • 15.4.9.4. Financial Insights
      • 15.4.9.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 15.4.9.6. SWOT Analysis
      • 15.4.9.7. Geographic Footprint
    • 15.4.10. Mylan N.V. (Viatris)
      • 15.4.10.1. Company Details
      • 15.4.10.2. Business Overview
      • 15.4.10.3. Product Portfolio
      • 15.4.10.4. Financial Insights
      • 15.4.10.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 15.4.10.6. SWOT Analysis
      • 15.4.10.7. Geographic Footprint
    • 15.4.11. Sun Pharmaceutical Industries Ltd.
      • 15.4.11.1. Company Details
      • 15.4.11.2. Business Overview
      • 15.4.11.3. Product Portfolio
      • 15.4.11.4. Financial Insights
      • 15.4.11.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 15.4.11.6. SWOT Analysis
      • 15.4.11.7. Geographic Footprint
    • 15.4.12. Cipla Inc.
      • 15.4.12.1. Company Details
      • 15.4.12.2. Business Overview
      • 15.4.12.3. Product Portfolio
      • 15.4.12.4. Financial Insights
      • 15.4.12.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 15.4.12.6. SWOT Analysis
      • 15.4.12.7. Geographic Footprint
    • 15.4.13. Dr. Reddy's Laboratories Ltd.
      • 15.4.13.1. Company Details
      • 15.4.13.2. Business Overview
      • 15.4.13.3. Product Portfolio
      • 15.4.13.4. Financial Insights
      • 15.4.13.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 15.4.13.6. SWOT Analysis
      • 15.4.13.7. Geographic Footprint
    • 15.4.14. Lupin Limited
      • 15.4.14.1. Company Details
      • 15.4.14.2. Business Overview
      • 15.4.14.3. Product Portfolio
      • 15.4.14.4. Financial Insights
      • 15.4.14.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 15.4.14.6. SWOT Analysis
      • 15.4.14.7. Geographic Footprint
    • 15.4.15. Laboratoire HRA Pharma (Perrigo)
      • 15.4.15.1. Company Details
      • 15.4.15.2. Business Overview
      • 15.4.15.3. Product Portfolio
      • 15.4.15.4. Financial Insights
      • 15.4.15.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 15.4.15.6. SWOT Analysis
      • 15.4.15.7. Geographic Footprint
    • 15.4.16. Endo International plc
      • 15.4.16.1. Company Details
      • 15.4.16.2. Business Overview
      • 15.4.16.3. Product Portfolio
      • 15.4.16.4. Financial Insights
      • 15.4.16.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 15.4.16.6. SWOT Analysis
      • 15.4.16.7. Geographic Footprint

List of Tables

• Table 1: Global Preterm Birth Prevention and Management Market Value (US$ Mn), By Drug Class, 2020-2035
• Table 2: Global Preterm Birth Prevention and Management Market Value (US$ Mn), By Route of Administration, 2020-2035
• Table 3: Global Preterm Birth Prevention and Management Market Value (US$ Mn), By End User, 2020-2035
• Table 4: Global Preterm Birth Prevention and Management Market Value (US$ Mn), By Region, 2020-2035
• Table 5: North America Preterm Birth Prevention and Management Market Value (US$ Mn), By Drug Class, 2020-2035
• Table 6: North America Preterm Birth Prevention and Management Market Value (US$ Mn), By Route of Administration, 2020-2035
• Table 7: North America Preterm Birth Prevention and Management Market Value (US$ Mn), By End User, 2020-2035
• Table 8: North America Preterm Birth Prevention and Management Market Value (US$ Mn), By Country, 2020-2035
• Table 9: The US Preterm Birth Prevention and Management Market Value (US$ Mn), By Drug Class, 2020-2035
• Table 10: The US Preterm Birth Prevention and Management Market Value (US$ Mn), By Route of Administration, 2020-2035
• Table 11: The US Preterm Birth Prevention and Management Market Value (US$ Mn), By End User, 2020-2035
• Table 12: Canada Preterm Birth Prevention and Management Market Value (US$ Mn), By Drug Class, 2020-2035
• Table 13: Canada Preterm Birth Prevention and Management Market Value (US$ Mn), By Route of Administration, 2020-2035
• Table 14: Canada Preterm Birth Prevention and Management Market Value (US$ Mn), By End User, 2020-2035
• Table 15: Europe Preterm Birth Prevention and Management Market Value (US$ Mn), By Drug Class, 2020-2035
• Table 16: Europe Preterm Birth Prevention and Management Market Value (US$ Mn), By Route of Administration, 2020-2035
• Table 17: Europe Preterm Birth Prevention and Management Market Value (US$ Mn), By End User, 2020-2035
• Table 18: Europe Preterm Birth Prevention and Management Market Value (US$ Mn), By Country, 2020-2035
• Table 19: Germany Preterm Birth Prevention and Management Market Value (US$ Mn), By Drug Class, 2020-2035
• Table 20: Germany Preterm Birth Prevention and Management Market Value (US$ Mn), By Route of Administration, 2020-2035
• Table 21: Germany Preterm Birth Prevention and Management Market Value (US$ Mn), By End User, 2020-2035
• Table 22: The U.K. Preterm Birth Prevention and Management Market Value (US$ Mn), By Drug Class, 2020-2035
• Table 23: The U.K. Preterm Birth Prevention and Management Market Value (US$ Mn), By Route of Administration, 2020-2035
• Table 24: The U.K. Preterm Birth Prevention and Management Market Value (US$ Mn), By End User, 2020-2035
• Table 25: France Preterm Birth Prevention and Management Market Value (US$ Mn), By Drug Class, 2020-2035
• Table 26: France Preterm Birth Prevention and Management Market Value (US$ Mn), By Route of Administration, 2020-2035
• Table 27: France Preterm Birth Prevention and Management Market Value (US$ Mn), By End User, 2020-2035
• Table 28: Spain Preterm Birth Prevention and Management Market Value (US$ Mn), By Drug Class, 2020-2035
• Table 29: Spain Preterm Birth Prevention and Management Market Value (US$ Mn), By Route of Administration, 2020-2035
• Table 30: Spain Preterm Birth Prevention and Management Market Value (US$ Mn), By End User, 2020-2035
• Table 31: Italy Preterm Birth Prevention and Management Market Value (US$ Mn), By Drug Class, 2020-2035
• Table 32: Italy Preterm Birth Prevention and Management Market Value (US$ Mn), By Route of Administration, 2020-2035
• Table 33: Italy Preterm Birth Prevention and Management Market Value (US$ Mn), By End User, 2020-2035
• Table 34: Russia & CIS Preterm Birth Prevention and Management Market Value (US$ Mn), By Drug Class, 2020-2035
• Table 35: Russia & CIS Preterm Birth Prevention and Management Market Value (US$ Mn), By Route of Administration, 2020-2035
• Table 36: Russia & CIS Preterm Birth Prevention and Management Market Value (US$ Mn), By End User, 2020-2035
• Table 37: Rest of Europe Preterm Birth Prevention and Management Market Value (US$ Mn), By Drug Class, 2020-2035
• Table 38: Rest of Europe Preterm Birth Prevention and Management Market Value (US$ Mn), By Route of Administration, 2020-2035
• Table 39: Rest of Europe Preterm Birth Prevention and Management Market Value (US$ Mn), By End User, 2020-2035
• Table 40: Asia Pacific Preterm Birth Prevention and Management Market Value (US$ Mn), By Drug Class, 2020-2035
• Table 41: Asia Pacific Preterm Birth Prevention and Management Market Value (US$ Mn), By Route of Administration, 2020-2035
• Table 42: Asia Pacific Preterm Birth Prevention and Management Market Value (US$ Mn), By End User, 2020-2035
• Table 43: Asia Pacific Preterm Birth Prevention and Management Market Value (US$ Mn), By Country, 2020-2035
• Table 44: China Preterm Birth Prevention and Management Market Value (US$ Mn), By Drug Class, 2020-2035
• Table 45: China Preterm Birth Prevention and Management Market Value (US$ Mn), By Route of Administration, 2020-2035
• Table 46: China Preterm Birth Prevention and Management Market Value (US$ Mn), By End User, 2020-2035
• Table 47: India Preterm Birth Prevention and Management Market Value (US$ Mn), By Drug Class, 2020-2035
• Table 48: India Preterm Birth Prevention and Management Market Value (US$ Mn), By Route of Administration, 2020-2035
• Table 49: India Preterm Birth Prevention and Management Market Value (US$ Mn), By End User, 2020-2035
• Table 50: Japan Preterm Birth Prevention and Management Market Value (US$ Mn), By Drug Class, 2020-2035
• Table 51: Japan Preterm Birth Prevention and Management Market Value (US$ Mn), By Route of Administration, 2020-2035
• Table 52: Japan Preterm Birth Prevention and Management Market Value (US$ Mn), By End User, 2020-2035
• Table 53: South Korea Preterm Birth Prevention and Management Market Value (US$ Mn), By Drug Class, 2020-2035
• Table 54: South Korea Preterm Birth Prevention and Management Market Value (US$ Mn), By Route of Administration, 2020-2035
• Table 55: South Korea Preterm Birth Prevention and Management Market Value (US$ Mn), By End User, 2020-2035
• Table 56: ASEAN Preterm Birth Prevention and Management Market Value (US$ Mn), By Drug Class, 2020-2035
• Table 57: ASEAN Preterm Birth Prevention and Management Market Value (US$ Mn), By Route of Administration, 2020-2035
• Table 58: ASEAN Preterm Birth Prevention and Management Market Value (US$ Mn), By End User, 2020-2035
• Table 59: Australia & New Zealand Preterm Birth Prevention and Management Market Value (US$ Mn), By Drug Class, 2020-2035
• Table 60: Australia & New Zealand Preterm Birth Prevention and Management Market Value (US$ Mn), By Route of Administration, 2020-2035
• Table 61: Australia & New Zealand Preterm Birth Prevention and Management Market Value (US$ Mn), By End User, 2020-2035
• Table 62: Rest of Asia Pacific Preterm Birth Prevention and Management Market Value (US$ Mn), By Drug Class, 2020-2035
• Table 63: Rest of Asia Pacific Preterm Birth Prevention and Management Market Value (US$ Mn), By Route of Administration, 2020-2035
• Table 64: Rest of Asia Pacific Preterm Birth Prevention and Management Market Value (US$ Mn), By End User, 2020-2035
• Table 65: Middle East & Africa Preterm Birth Prevention and Management Market Value (US$ Mn), By Drug Class, 2020-2035
• Table 66: Middle East & Africa Preterm Birth Prevention and Management Market Value (US$ Mn), By Route of Administration, 2020-2035
• Table 67: Middle East & Africa Preterm Birth Prevention and Management Market Value (US$ Mn), By End User, 2020-2035
• Table 68: Middle East & Africa Preterm Birth Prevention and Management Market Value (US$ Mn), By Country, 2020-2035
• Table 69: GCC Preterm Birth Prevention and Management Market Value (US$ Mn), By Drug Class, 2020-2035
• Table 70: GCC Preterm Birth Prevention and Management Market Value (US$ Mn), By Route of Administration, 2020-2035
• Table 71: GCC Preterm Birth Prevention and Management Market Value (US$ Mn), By End User, 2020-2035
• Table 72: South Africa Preterm Birth Prevention and Management Market Value (US$ Mn), By Drug Class, 2020-2035
• Table 73: South Africa Preterm Birth Prevention and Management Market Value (US$ Mn), By Route of Administration, 2020-2035
• Table 74: South Africa Preterm Birth Prevention and Management Market Value (US$ Mn), By End User, 2020-2035
• Table 75: Rest of Middle East & Africa Preterm Birth Prevention and Management Market Value (US$ Mn), By Drug Class, 2020-2035
• Table 76: Rest of Middle East & Africa Preterm Birth Prevention and Management Market Value (US$ Mn), By Route of Administration, 2020-2035
• Table 77: Rest of Middle East & Africa Preterm Birth Prevention and Management Market Value (US$ Mn), By End User, 2020-2035
• Table 78: Latin America Preterm Birth Prevention and Management Market Value (US$ Mn), By Drug Class, 2020-2035
• Table 79: Latin America Preterm Birth Prevention and Management Market Value (US$ Mn), By Route of Administration, 2020-2035
• Table 80: Latin America Preterm Birth Prevention and Management Market Value (US$ Mn), By End User, 2020-2035
• Table 81: Latin America Preterm Birth Prevention and Management Market Value (US$ Mn), By Country, 2020-2035
• Table 82: Brazil Preterm Birth Prevention and Management Market Value (US$ Mn), By Drug Class, 2020-2035
• Table 83: Brazil Preterm Birth Prevention and Management Market Value (US$ Mn), By Route of Administration, 2020-2035
• Table 84: Brazil Preterm Birth Prevention and Management Market Value (US$ Mn), By End User, 2020-2035
• Table 85: Mexico Preterm Birth Prevention and Management Market Value (US$ Mn), By Drug Class, 2020-2035
• Table 86: Mexico Preterm Birth Prevention and Management Market Value (US$ Mn), By Route of Administration, 2020-2035
• Table 87: Mexico Preterm Birth Prevention and Management Market Value (US$ Mn), By End User, 2020-2035
• Table 88: Rest of Latin America Preterm Birth Prevention and Management Market Value (US$ Mn), By Drug Class, 2020-2035
• Table 89: Rest of Latin America Preterm Birth Prevention and Management Market Value (US$ Mn), By Route of Administration, 2020-2035
• Table 90: Rest of Latin America Preterm Birth Prevention and Management Market Value (US$ Mn), By End User, 2020-2035

List of Figures

• Figure 1: Global Preterm Birth Prevention and Management Market Value (US$ Mn), 2020-2035
• Figure 2: Global Preterm Birth Prevention and Management Market Value Share (%) Analysis, By Drug Class, 2025 & 2035
• Figure 3: Global Preterm Birth Prevention and Management Market Value Share (%) Analysis, By Route of Administration, 2025 & 2035
• Figure 4: Global Preterm Birth Prevention and Management Market Value Share (%) Analysis, By End User, 2025 & 2035
• Figure 5: Global Preterm Birth Prevention and Management Market Value Share (%) Analysis, By Region, 2025 & 2035
• Figure 6: Global Preterm Birth Prevention and Management Market Value Share (%) Analysis, By Drug Class, 2020, 2025 and 2035
• Figure 7: Global Preterm Birth Prevention and Management Market Attractiveness Analysis, By Drug Class
• Figure 8: Global Preterm Birth Prevention and Management Market Value Share (%) Analysis, By Route of Administration, 2020, 2025 and 2035
• Figure 9: Global Preterm Birth Prevention and Management Market Attractiveness Analysis, By Route of Administration
• Figure 10: Global Preterm Birth Prevention and Management Market Value Share (%) Analysis, By End User, 2020, 2025 and 2035
• Figure 11: Global Preterm Birth Prevention and Management Market Attractiveness Analysis, By End User
• Figure 12: Global Preterm Birth Prevention and Management Market Value Share (%) Analysis, By Region, 2020, 2025 and 2035
• Figure 13: Global Preterm Birth Prevention and Management Market Attractiveness Analysis, By Region
• Figure 14: North America Preterm Birth Prevention and Management Market Value Share (%) Analysis, By Drug Class, 2020, 2025 and 2035
• Figure 15: North America Preterm Birth Prevention and Management Market Attractiveness Analysis, By Drug Class
• Figure 16: North America Preterm Birth Prevention and Management Market Value Share (%) Analysis, By Route of Administration, 2020, 2025 and 2035
• Figure 17: North America Preterm Birth Prevention and Management Market Attractiveness Analysis, By Route of Administration
• Figure 18: North America Preterm Birth Prevention and Management Market Value Share (%) Analysis, By End User, 2020, 2025 and 2035
• Figure 19: North America Preterm Birth Prevention and Management Market Attractiveness Analysis, By End User
• Figure 20: North America Preterm Birth Prevention and Management Market Value Share (%) Analysis, By Country, 2020, 2025 and 2035
• Figure 21: North America Preterm Birth Prevention and Management Market Attractiveness Analysis, By Country
• Figure 22: Europe Preterm Birth Prevention and Management Market Value Share (%) Analysis, By Drug Class, 2020, 2025 and 2035
• Figure 23: Europe Preterm Birth Prevention and Management Market Attractiveness Analysis, By Drug Class
• Figure 24: Europe Preterm Birth Prevention and Management Market Value Share (%) Analysis, By Route of Administration, 2020, 2025 and 2035
• Figure 25: Europe Preterm Birth Prevention and Management Market Attractiveness Analysis, By Route of Administration
• Figure 26: Europe Preterm Birth Prevention and Management Market Value Share (%) Analysis, By End User, 2020, 2025 and 2035
• Figure 27: Europe Preterm Birth Prevention and Management Market Attractiveness Analysis, By End User
• Figure 28: Europe Preterm Birth Prevention and Management Market Value Share (%) Analysis, By Country, 2020, 2025 and 2035
• Figure 29: Europe Preterm Birth Prevention and Management Market Attractiveness Analysis, By Country
• Figure 30: Asia Pacific Preterm Birth Prevention and Management Market Value Share (%) Analysis, By Drug Class, 2020, 2025 and 2035
• Figure 31: Asia Pacific Preterm Birth Prevention and Management Market Attractiveness Analysis, By Drug Class
• Figure 32: Asia Pacific Preterm Birth Prevention and Management Market Value Share (%) Analysis, By Route of Administration, 2020, 2025 and 2035
• Figure 33: Asia Pacific Preterm Birth Prevention and Management Market Attractiveness Analysis, By Route of Administration
• Figure 34: Asia Pacific Preterm Birth Prevention and Management Market Value Share (%) Analysis, By End User, 2020, 2025 and 2035
• Figure 35: Asia Pacific Preterm Birth Prevention and Management Market Attractiveness Analysis, By End User
• Figure 36: Asia Pacific Preterm Birth Prevention and Management Market Value Share (%) Analysis, By Country, 2020, 2025 and 2035
• Figure 37: Asia Pacific Preterm Birth Prevention and Management Market Attractiveness Analysis, By Country
• Figure 38: Middle East & Africa Preterm Birth Prevention and Management Market Value Share (%) Analysis, By Drug Class, 2020, 2025 and 2035
• Figure 39: Middle East & Africa Preterm Birth Prevention and Management Market Attractiveness Analysis, By Drug Class
• Figure 40: Middle East & Africa Preterm Birth Prevention and Management Market Value Share (%) Analysis, By Route of Administration, 2020, 2025 and 2035
• Figure 41: Middle East & Africa Preterm Birth Prevention and Management Market Attractiveness Analysis, By Route of Administration
• Figure 42: Middle East & Africa Preterm Birth Prevention and Management Market Value Share (%) Analysis, By End User, 2020, 2025 and 2035
• Figure 43: Middle East & Africa Preterm Birth Prevention and Management Market Attractiveness Analysis, By End User
• Figure 44: Middle East & Africa Preterm Birth Prevention and Management Market Value Share (%) Analysis, By Country, 2020, 2025 and 2035
• Figure 45: Middle East & Africa Preterm Birth Prevention and Management Market Attractiveness Analysis, By Country
• Figure 46: Latin America Preterm Birth Prevention and Management Market Value Share (%) Analysis, By Drug Class, 2020, 2025 and 2035
• Figure 47: Latin America Preterm Birth Prevention and Management Market Attractiveness Analysis, By Drug Class
• Figure 48: Latin America Preterm Birth Prevention and Management Market Value Share (%) Analysis, By Route of Administration, 2020, 2025 and 2035
• Figure 49: Latin America Preterm Birth Prevention and Management Market Attractiveness Analysis, By Route of Administration
• Figure 50: Latin America Preterm Birth Prevention and Management Market Value Share (%) Analysis, By End User, 2020, 2025 and 2035
• Figure 51: Latin America Preterm Birth Prevention and Management Market Attractiveness Analysis, By End User
• Figure 52: Latin America Preterm Birth Prevention and Management Market Value Share (%) Analysis, By Country, 2020, 2025 and 2035
• Figure 53: Latin America Preterm Birth Prevention and Management Market Attractiveness Analysis, By Country